Ownership history in Kynam Capital Management, LP · 7 quarters on record
This page tracks every 13F SEC filing in which Kynam Capital Management, LP reported a position in IRONWOOD PHARMACEUTICALS INC (IRWD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 5,466,825 | — | 0% | 0.53% | $7.2M | $1.31 |
| 2025 Q2 | REDUCED | 5,466,825 | -356,113 | -6.1% | 0.42% | $3.9M | $0.72 |
| 2025 Q1 | ADDED | 5,822,938 | +1,137,375 | +24.3% | 0.72% | $8.6M | $1.47 |
| 2024 Q4 | ADDED | 4,685,563 | +1,000,000 | +27.1% | 1.23% | $20.8M | $4.43 |
| 2024 Q3 | ADDED | 3,685,563 | +2,043,672 | +124.5% | 1.16% | $15.2M | $4.12 |
| 2024 Q2 | ADDED | 1,641,891 | +16,891 | +1.0% | 0.83% | $10.7M | $6.52 |
| 2024 Q1 | INITIATED | 1,625,000 | — | — | 1.48% | $14.2M | — |
As of 2025 Q4 — sorted by position size